Bayer Settles Multi-Million With Hemophiliacs Over HIV Tainted Blood

The Coalition Against Bayer pharmaceuticals (CBG) announces that Bayer and Baxter settled a mulit-million dollar compensation suit with hemophiliacs in 22 countries who were victims, infected with HIV or hepatitis C having been infused with tainted blood plasma products in the 1980s.

In 2003, The New York Times reported that a division of Bayer pharmaceutical KNOWINGLY continued to sell its AIDS infected blood product to countries in Asia and Latin America to get rid of inventory: "the company hoped to preserve the profit margin from 'several large fixed-price contracts." The Bayer-Baxter settlement prohibits the victims and their lawyers from speaking about the arrangement.